Today’s CSR movers
ETR 4.0 ▲ 1.5
SO 3.0 ▲ 1.0
NTAP 3.6 ▲ 0.5
PWR 4.6 ▲ 0.5
SNPS 4.6 ▲ 0.5
APA 3.1 ▲ 0.1
ITW 2.7 ▲ 0.1
CF 2.9 ▼ 0.1
VMC 3.7 ▼ 0.1
COO 3.6 ▼ 0.1
Health Care · NYSE NYSE · MTD

Mettler Toledo

$1,293.52 +$13.06 +1.01% CLOSE 09.11.26 AFTER HOURS $1,293.52
Convergence score
3.1 / 5.0 NEUTRAL
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$1,450.45 +12.1%
Range $1,194.00 — $1,600.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 09.11.26
UV Convergence Score
REPORT 09.11.26
3.1
/ 5.0
NEUTRAL
Consensus signal A
3.0
Consensus signal B
3.0
Consensus signal D
3.0
Analyst average
3.4
Multi-signal aggregate How CSR works →
Day Range
$1,286.66 – $1,302.85
52W Range
$1,023.05 – $1,525.17
Volume
93.9K
Avg Vol
187.3K
Mkt Cap
$25.92B
P/E
29.19
EPS (TTM)
$44.31
Div Yield
Beta
1.22
Today's convergence

Convergence score sits at 3.1 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
NEUTRAL
Last close
$1,293.52
Sector
Health Care
Valuation
Three horizons
UPDATED 09.11.26
Short term
0–3 MO
No target
Medium term
3–12 MO
$1,446+11.8% Hold
Long term
12–36 MO
$830.02-35.8% Overvalued
Open valuation
Analysts
Coverage & consensus
5 PANELS
Mean target (12mo)
$1,450.45 +12.1%
RANGE $1,194.00 — $1,600.00
Analyst consensus
Consensus rating Hold
Blended score 3.1 / 5
Analysts tracked 81
Open analysts
Financials
Key metrics
LATEST
P/E
29.19
EPS (TTM)
$44.31
Mkt Cap
$25.92B
Div Yield
Beta
1.22
52W Range
$1,023.05 – $1,525.17
Open financials
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in
Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26
Short term
0–3 MO
Consensus target
No target available
Medium term
3–12 MO
Hold
Consensus target
$1,446 +11.8%
RANGE $1,194 – $1,600
$1,194NOW $1,293.52$1,600

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$830.02 -35.8%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Analyst coverage

Blended analyst consensus & targets.

5 PANELS · UPDATED 09.11.26
Analyst consensus
Rating Blended score Panels Analysts
Hold 3.1 5 81
Price targets
Coverage Low Mean Median High Upside
All panels $1,194.00 $1,450.45 $1,460.00 $1,600.00 +12.1%
Rating distribution
Coverage SB B H S SS
All panels 1 10 17 2 1
Rating trend
Period Rating Avg Analysts
Current
1 Mo Ago
2 Mo Ago
3 Mo Ago
Most recent analyst action
Date
9/9/2026
Firm
UBS Group
Action
Initiated Coverage
Rating
Buy ➝ Neutral
Target
$1,460.00
Financials

Full financial snapshot.

UPDATED 09.11.26
Quote snapshot
Prev Close
$1,280.58
Open
$1,294.03
Day Low
$1,286.66
Day High
$1,302.85
Bid
$1,291.74
Ask
$1,295.84
52W Low
$1,023.05
52W High
$1,525.17
50D Avg
$1,362.53
200D Avg
$1,317.95
Volume
93.9K
Avg Vol
187.3K
10D Avg Vol
171.9K
52W Change
1.67%
S&P 52W Change
15.30%
Valuation ratios
P/E (TTM)
29.19
P/E (Fwd)
25.02
PEG (Fwd)
2.40
P/S
6.27
P/B
2021.13
Book Value
$0.64
EV/Revenue
6.77
EV/EBITDA
21.95
Mkt Cap
25.92B
Enterprise Val
28B
Profitability & returns
Profit Margin
21.91%
Gross Margin
60.26%
Operating Margin
31.20%
EBITDA Margin
30.86%
Return on Assets
21.10%
Return on Equity
Growth
Revenue Growth (YoY)
4.50%
Earnings Growth (YoY)
18.30%
Earnings Growth (Q)
15.10%
Balance sheet & cash flow
Total Revenue
4.13B
EBITDA
1.28B
Total Cash
51.38M
Total Debt
2.14B
Cash / Share
$2.56
Revenue / Share
$203.41
Free Cash Flow
693.59M
Operating CF
975.17M
Debt / Equity
16668.45
Current Ratio
1.12
Quick Ratio
0.66
Dividend
Fwd Dividend
Dividend Yield
Payout Ratio
0.00%
5Y Avg Yield
Ex-Div Date
Share statistics
Shares Out
20.04M
Float
19.93M
Shares Short
634.4k
% Short of Float
3.64%
Short Ratio
3.60
% Held Insiders
0.44%
% Held Institutions
105.41%
Calendar & events
Next Earnings
2026-11-05
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-06-30
Last Split
Split Date
Company
Industry
Diagnostics & Research
Employees
16,600